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Arterial stiffness in hypertensive and type 2
diabetes patients in Ghana: comparison of
the cardio-ankle vascular index and central
aortic techniques
Kwame Yeboah1* , Daniel A. Antwi1, Ben Gyan2, Virginia Govoni3, Charlotte E. Mills3, J. Kennedy Cruickshank3†
and Albert G. B. Amoah4,5†
Abstract
Background: Diabetes and hypertension increase arterial stiffness and cardiovascular events in all societies studied
so far; sub-Saharan African studies are sparse. We investigated factors affecting arterial function in Ghanaians with
diabetes, hypertension, both or neither.
Method: Testing the hypothesis that arterial stiffness would progressively increase from controls to multiply
affected patients, 270 participants were stratified into those with diabetes or hypertension only, with both, or
without either. Cardio-ankle vascular index (CAVI), heart–ankle pulse wave velocity (haPWV), aortic PWV (PWVao)
by Arteriograph, aortic and brachial blood pressures (BP), were measured.
Results: In patients with both diabetes and hypertension compared with either alone, values were higher of
CAVI (mean ± SD, 8.3 ± 1.2 vs 7.5 ± 1.1 and 7.4 ± 1.1 units; p < 0.05), PWVao (9.1 ± 1.4 vs 8.7 ± 1.9 and 8.1 ± 0.
9 m/s; p < 0.05) and haPWV (8.5 ± 1 vs 7.9 ± 1 and 7.2 ± 0.7 m/s; p < 0.05) respectively. In multivariate analysis,
age, having diabetes or hypertension and BMI were independently associated with CAVI in all participants (β = 0.49, 0.2,
0.17 and -0.2 units; p < 0.01, respectively). Independent determinants of PWVao were heart rate, systolic BP and
age (β = 0.42, 0.27 and 0.22; p < 0.01), and for haPWV were systolic BP, age, BMI, diabetes and hypertension status
(β = 0.46, 0.32, -0.2, 0.2 and 0.11; p < 0.01).
Conclusion: In this sub-Saharan setting with lesser atherosclerosis than the western world, arterial stiffness is
significantly greater in patients with coexistent diabetes and hypertension but did not differ between those with
either diabetes or hypertension only. Simple, reproducibly measured PWV/CAVI may offer effective and efficient
targets for intervention.
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Background
Epidemiological transition has been underway for many
years in most lower/middle income countries, as in
Ghana. Chronic adult diseases including hypertension,
obesity, resulting metabolic syndrome and diabetes are
now common [1, 2]. Consequently, premature macro-
and micro-vascular conditions, including hypertensive
heart failure (if not yet much coronary disease), stroke,
renal failure, and arterial complications of Type 2
diabetes (T2D) now burden patients and health services
[3, 4]. Arterial stiffness is a powerful predictor of such
future cardiovascular (CV) complications and all-cause
mortality in all patient groups studied, even after
adjusting for age, blood pressure (BP) or other risk
factors [5, 6]. In addition, arterial stiffness is one of
the earliest detectable manifestations of adverse struc-
tural and functional changes within the vessel wall
[7]. The gold standard for measuring arterial (aortic)
stiffness is carotid-femoral pulse wave velocity [8].
Cardio-ankle vascular index (CAVI), an index of arterial
stiffness developed in Japan from measuring heart-ankle
PWV (haPWV) and brachial BP, is reported to be inde-
pendent from BP at the time of measurement; hence
CAVI may indicate organic stiffness of the arterial wall,
minimising the influence of BP fluctuations [9].
There is little arterial function research in sub-
Saharan Africa population, and none to our know-
ledge, on CAVI and haPWV in patients with T2D or
hypertension [10]. We used CAVI and another cali-
brated cuff-based device, the Arteriograph, to measure
aortic PWV to test the hypothesis that arterial stiff-
ness would progressively increase with increasing
burden of CV risk, mainly as having hypertension or
Type 2 diabetes in Ghanaians.
Methods
Study design and patients
The study was performed at the National Diabetes
Management and Research Centre, Accra, established in
1995 as a centre of excellence for diabetes research,
management and education in Ghana. In all, 300 partici-
pants, aged 30–75 years, without type 1 diabetes or overt
CVDs, were recruited as every 3rd person attending
clinics. Healthy volunteers from the community who
were glucose tolerance tested and did not have T2D
served as controls. There were 210 T2D patients, with
90 age-matched non-diabetes volunteers. In the final
analysis, 30 out of the 300 participants were excluded:
24 due to ankle-brachial index <0.90 or other poor arter-
ial wave tracings; 6 had intermediate fasting plasma glu-
cose (FPG) or 2-h post 75 g glucose load plasma glucose
(2 h-PPG) above the threshold for non-diabetes. The
remaining sample of 270 included 192 T2D patients, 143
with and 49 without defined ‘hypertension’ (BP ≥140 or
90 mmHg or on treatment); 50 hypertensives without
T2D and 28 controls without hypertension or diabetes.
T2D status was clinical, based on not requiring insulin
at diagnosis of diabetes and older age of presentation
(>35 years). Ethical approval came from the University
of Ghana Medical School Ethical and Protocol Review
Committee (Protocol ID number: MS-Et/M.2 – P.4.10/
2012-2013); all participants gave written informed
consent after thorough explanation of the procedures
involved.
Anthropometric measurements
Using standard protocols [11], waist and hip circum-
ferences were measured in duplicate with a non-
elastic tape, maximum height to the nearest 0.1 cm
using a Stadiometer, and weight to the nearest 0.1 kg
on a digital, heavy-duty floor scale (Seca, Hamburg,
Germany). Percentage body fat was assessed using the
Body composition monitor (BF- 508, Omron Healthcare,
Inc., Vernon Hills, IL, USA).
Biochemical analysis
Blood samples were drawn in the morning after 8–12 h
of overnight fasting into plain vacuum tubes to measure
plasma lipids and fluoride oxalate tubes for glucose
levels. FPG, 2-h PPG, total cholesterol (TC), high-
density lipoprotein cholesterol (HDL) and triglyceride
(TG) levels were analysed by colorimetric enzymatic
assays using BS 120 chemical autoanalyser (Mindray,
China) and commercial reagents (Randox Laboratory
Reagents, UK). Low-density lipoprotein cholesterol levels
were calculated using Friedewald’s formula [12]. All ana-
lyses were performed at the Diabetes Research and
Chronic Disease Reference Laboratory.
Cardiovascular measurements
Brachial and aortic pressure indices, aortic PWV
(PWVao), and aortic augmentation index (AIx) were
measured with Arteriograph (TensioMed Kft., Hungary),
with the subject lying supine, after 10 min rest in a
temperature controlled room (22 ± 2 °C). The Arterio-
graph cuff was applied on the right arm over the
brachial artery to detect arterial wall oscillations in the
upper arm using the ‘stop-flow’ principle previously de-
scribed [13], and analysed using dedicated software.
CAVI and haPWV were measured using the Vasera
1500 N (Fukuda-Denshi, Japan) with the participant
resting supine for at least 10 min before the measure-
ment. Electrocardiogram electrodes were placed on
both wrists, a microphone for detecting heart sounds
on the sternum, and cuffs were wrapped around both
upper arms and above each ankle. CAVI values were
computed automatically. Briefly, CAVI corresponds to
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the stiffness parameter β, calculated from values of
heart-ankle PWV and BP as follows;
β ¼ 2ρ=ΔPð Þ In Ps=Pdð Þ½ PWV2
Where ρ indicates blood density; ΔP, pulse pressure; In,
natural log; Ps, systolic BP; and Pd, diastolic BP [9, 14].
CAVI and Arteriograph measures were done in ran-
dom order from a digital algorithm.
Statistical analysis
IBM SPSS version 20 was used to summarise results as
proportions for categorical variables and means and
standard deviations (SD) for continuous variables. Mean
differences between groups of patients were analysed by
ANOVA, categorical data by χ2 test, and association
between variables using Pearson’s correlation. Multiple
regressions, with all appropriate parameters (eg, just 1
BP type, systolic or pulse pressure etc) forced into the
model, were performed to determine independent deter-
minants of CAVI, aortic PWV and haPWV. p-values <
0.05 were considered statistically significant.
Results
Characteristics of study participants
Clinical and haemodynamic characteristics of 270 partic-
ipants with quality waveforms showed no significant dif-
ference in age, gender or former smoking, although
controls were somewhat younger (Table 1). As expected,
hypertensive T2D patients had the highest PWVao,
greater than those with T2D only and hypertension only;
both these groups had higher PWVao than controls.
Similarly, hypertensive T2D had significantly higher
CAVI and haPWV than hypertensives only, T2D only
and controls. Despite their marginally higher BPs, the
‘healthy’ controls had lower PWVao, CAVI and haPWV
than patients with T2D alone. Aortic pressure indices in
hypertensive T2D and hypertensive only patients were
also higher than in T2D only patients. T2D patients had
lower total and LDL cholesterol (with statin treatment
as shown) than non-diabetes patients (Additional file 1:
Table S1).
Correlation between indices of arterial stiffness and
patient parameters
In univariate analysis, CAVI was associated with age,
waist-hip ratio, pulse and mean BP in all participants.
For combined patients group, CAVI was also associated
with body fat. In controls, CAVI was positively associ-
ated with age and fasting triglycerides levels. However,
in all groups, CAVI was not associated with systolic/dia-
stolic BPs, heart rate and plasma glucose and lipid pro-
file. (Additional file 1: Table S2). In all participants and
combined patient groups, PWVao was associated with
age, BMI, body fat, systolic/diastolic BPs, mean BP, pulse
pressure and heart rate. In controls, PWVao was associ-
ated with age only (Additional file 1: Table S3). Heart-
ankle PWV was associated with age, waist-hip ratio,
systolic/diastolic BPs, pulse pressure and mean BP in
both all participants and combined patient groups
(Additional file 1: Table S4).
When PWVao was plotted against the range of aortic
systolic BPs (Fig. 1), at any level of BP in all groups,
there were participants with lower BP who had stiffer ar-
teries, as was also found with brachial pressures (Fig. 2).
Similar observations were also made with a plot of CAVI
against brachial systolic BP (Additional file 2: Figure S2),
even if there was no significant relationship between
them. At lower BP levels in all groups, some individuals
had higher levels of ‘intrinsic’ arterial stiffness independ-
ent of BP, which is CAVI. (Additional file 2: Figure S1).
Multiple linear regressions
In multiple regression analyses (Table 2), in all partici-
pants and combined patients groups, CAVI was posi-
tively and independently related to age, most strongly,
then to hypertension &/or diabetes status, WHR and
prominently negatively to BMI. However, in controls,
only age was a determinant of CAVI. Systolic BP made
no significant contribution to variation in CAVI. When
systolic BP was substituted with other brachial pressures
– diastolic, mean or pulse – none were significantly asso-
ciated with CAVI (data not shown – but see Additional
file 2: Figure S2 for Systolic BP vs CAVI plot).
For haPWV (Table 3), in all participants and combined
patients group, systolic BP, age and hypertension status
had positive relationships and again BMI made a
negative contribution. T2D status was independently as-
sociated with haPWV in all participants but not in com-
bined patients group. In controls, age and systolic BP
contributed significantly to haPWV. Heart rate, systolic
BP and age each contributed significantly to variation in
PWVao in all participants, but none of the cardiovascu-
lar risk factors were independently associated with
PWVao in the controls.
Discussion
Our findings suggest that these indices of arterial stiff-
ness, CAVI, haPWV from which CAVI is derived, and
PWVao are significantly increased in Ghanaian patients
with diabetes and hypertension more than in those with
either alone, or without both conditions. Our data here
are the first from a sub-Saharan African patient popula-
tion where generally, atheromatous disease is still un-
common; haemorrhagic stroke, hypertensive heart and
renal failure remain the major causes of vascular events
[15]. There was no difference in CAVI and PWVao values
between diabetes without hypertension, and hypertension
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patients without diabetes, suggesting that both conditions
are similarly related to arterial pathology, even when the
CAVI computation adjusts for BP differences. That con-
clusion is supported by the similar heart-ankle pathway
PWV data, which has to be extracted from the software
(based on the time delay between the phonocardiogram’s
2nd sound to arrival of the pressure wave at the ankle).
While the PWV of the so-called brachial-ankle arterial
pathway, in general use in Japan, is prognostic [16], its
cardiac-brachial component is not.
The key importance of arterial stiffness is that its prog-
nostic value persists when other known risk factors in-
cluding any BP (systolic, pulse or mean) have been taken
into consideration [17]. Cruickshank et al. [18] showed
how arterial stiffness, measured by aortic PWV, pre-
dicted mortality in T2D patients, in those with ‘impaired’
glycaemia and in glucose-challenged controls and hence
that arterial PWV could be considered an integrated
index of vascular health. That sample included African-
Caribbeans, who still have lower coronary heart disease,
Table 1 Clinical characteristics of participants
Characteristics Controls (n = 28) T2D only (n = 49) Hypertensive only (n = 50) Hypertensive T2D (n = 143)
Age 51.5 ± 11.8 52.8 ± 8.7 56.1 ± 9.4 57.1 ± 9.7
Male gender, n (%) 15 (53.6) 33 (67.3) 17 (34) 64 (44.8)
BMI (kg/m2) 28.8 ± 5.2 26.1 ± 3.6 30 ± 5.6 29.7 ± 5.3
Ex-smokers, n (%) 5 (17.9) 6 (12.2) 11 (22) 5 (3.4)
Medications n (%)
on Antihyper-tensive Treatment NA NA 39 (78) 90 (62.9)
on insulin 7 (14.3) 45 (31.5)
on oral hypoglycaemics 10 (28.6) 39 (27.3)
On insulin plus oral hypoglycaemics 20 (40.8) 59 (41.3)
On Statins 0 23 (46.9) 6 (12) 38 (26.6)
Duratn.T2D (yrs) NA 7 ± 6 NA 11 ± 8#
Vasera Measures
SBP (mm Hg) 128 ± 15 125 ± 29 150 ± 29*# 149 ± 34*#
DBP (mm Hg) 80 ± 7 83 ± 8 93 ± 12*# 92 ± 10*#
PP (mm Hg) 48 ± 11 47 ± 9 57 ± 14*# 63 ± 15*#
MBP (mm Hg) 96 ± 9 99 ± 9 112 ± 14*# 112 ± 12*#
H Rate (bpm) 64 ± 10 74 ± 11 69 ± 11 78 ± 13
CAVIa 6.9 ± 1 7.4 ± 1.1* 7.5 ± 1.1* 8.3 ± 1.2*§#
haPWV (m/s) a 6.9 ± 0.8 7.2 ± 0.7* 7.9 ± 1* 8.5 ± 1*§#
Arteriograph Measures
Brachial Pressure
SBP 124 ± 10 123 ± 20 144 ± 35*# 152 ± 30*#
DBP 74 ± 9 75 ± 9 88 ± 13*# 88 ± 13*#
PP 50 ± 6 51 ± 7 62 ± 12*# 67 ± 14*#
MBP 90 ± 9 92 ± 8 108 ± 14*# 110 ± 14*#
HR 65 ± 10 73 ± 16 66 ± 22 75 ± 16
Aortic Pressure
Aortic SBP 120 ± 12 116 ± 12 148 ± 27*# 151 ± 26*#
Aortic PP 46 ± 7 39 ± 14 65 ± 17*# 58 ± 25*#
Aortic AIx 29 ± 13 19 ± 11 38 ± 11*# 30 ± 15*#§
Aortic PWV 7.8 ± 1.1 8.1 ± 0.9* 8.7 ± 1.9* 9.1 ± 1.4*#§
T2D type 2 diabetes, BMI body mass index, CAVI cardio-ankle vascular index, haPWV heart-ankle pulse wave velocity, SBP systolic blood pressure, DBP diastolic
blood pressure, PP pulse pressure, MBP mean blood pressure, HR heart rate, PWV pulse wave velocity, AIx augmentation index
aAdjusted for age and gender
*vs Controls, p < 0.05
§ vs Hypertensive only, p < 0.05
# vs T2D only, p < 0.05
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but not stroke, risk than the British population average;
similar to but not as extreme a difference as in Ghana.
CAVI, a novel index, is thought to reflect collective over-
all compliance in the aorta, femoral and popliteal arter-
ies, independent of BP, based on the formula quoted
above (Methods) [9]. CAVI has also been shown to be
superior to ankle-brachial PWV in predicting cardiovas-
cular events. This superiority of CAVI had been attrib-
uted to its independence, theoretically, from BP at the
time of measurement, so that CAVI may indicate the in-
trinsic stiffness of the arterial wall [9, 14, 19]. CAVI may
also be a useful screening tool for moderate to advanced
levels of arterio-, rather than athero-sclerosis [20], the
major difference between traditionally high ‘BP’- and
plaque- driven pathology. We found that patients with
co-existent diabetes and hypertension have dramatic re-
duction arterial compliance, or increase stiffness, than
patients with single condition. The lack of difference in
CAVI/haPWV but a clearer difference in the Arterio-
graph’s PWVao between the T2D without hypertension
and hypertension group without T2D suggest less ar-
teriosclerosis in the more muscular peripheral arteries in
the legs here. In indigenous black South Africans, where
smoking rate and atherosclerosis remain (currently) low,
arterial stiffness as carotid-femoral PWV is still
pressure-dependent [21]. Such data illustrate how PWV
generally and CAVI may add value to a routine BP
‘check’. Without sub-Saharan intervention trials, their
routine use will not yet be judged ‘cost-effective’.
Most studies where arterial stiffness was evaluated
using CAVI have been performed in non-African, South-
East Asian populations [9, 14, 19, 20]. In agreement with
our findings, Wang et al [22] showed that CAVI is ele-
vated in a Chinese population with coexistent hyperten-
sion and diabetes. The dynamics of CAVI, as an index of
arterial stiffness in sub-Saharan Africans, may differ
from that in Asians or Caucasians [23], as found by
Uurtuya et al in comparable healthy young subjects [24]
and hypertensive T2D patients in Japan and Mongolia
[25]. Arterial stiffness measured by PWV here should re-
flect arterial function in these patient samples, but due
to the relatively small number of controls, estimating
general stiffness in sub-Saharan African populations at
large will need community-based population studies.
The major determinants of PWVao in this study were
heart rate, systolic BP and age. PWV, as a measure of ar-
terial stiffness, is affected by BP variation, independent
of intrinsic stiffness. Changes in heart rate greatly affect
variation in pulse waveform amplification from aortic
segments to peripheral arteries, increasing the brachial
systolic BP [26]. Heart rate in the multivariate model
may mask variation in PWVao due to diabetes and
hypertension status. When heart rate was removed
from the model (data not shown), diabetes (β = 0.122,
p = 0.027) and hypertension status (β = 0.207, p < 0.001)
became independently associated with PWVao. CAVI, un-
like PWVao, was not related to heart rate nor to BP in
multivariate regression, even when systolic BP was
substituted with diastolic, mean or pulse pressures (data
not shown), as found elsewhere [27]. The capture of
standard major CVD risk factors by CAVI is similar to
other reports [20, 24, 28, 29]. Contrary to other studies
Fig. 1 Aortic stiffness across various aortic systolic BP levels
Fig. 2 Aortic stiffness across various brachial systolic BP levels
Table 2 Multiple linear regression analysis for CAVI and subject
parameters
Entire group Control group Patient groups combined
β p β p β p
Age 0.49 <0.01 0.49 0.04 0.48 <0.01
Gender 0.06 0.281 -0.19 0.2 0.09 0.131
HTN status 0.2 <0.01 0.2 0.01
BMI -0.2 <0.01 0.08 0.34 -0.25 <0.01
T2D status 0.17 <0.01 0.13 0.01
WHR 0.09 0.09 0.08 0.74 0.18 <0.01
SBP * 0.09 0.1 0.21 0.23 0.1 0.11
Heart rate 0.04 0.45 -0.23 0.29 0.07 0.23
β = standardised regression coefficient
* = Values for Pulse pressure and mean BP were also not significant
HTN hypertension, T2D type 2 diabetes, BMI body mass index, CAVI cardio-
ankle vascular index, SBP systolic blood pressure, HR heart rate
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[28–30], none of the biochemical parameters predicted
variation in CAVI values here. This might be the result of
a robust model; all the independent variables were simul-
taneously forced into the regression. The model attempts
to mimic the complex interaction among various cardio-
vascular risk factors in vivo.
CAVI and haPWV had independent positive associ-
ation with age but negative with BMI in all participants.
The effect of age on CAVI was stronger in healthy par-
ticipants, similar to Japanese studies, where CAVI in-
creased at a rate of 0.5units/10 years in both men and
women [31]. We speculate that the U-shape relationship
between most anthropometric measurements and vascu-
lar health [32] may explain the negative association of
anthropometric indices with CAVI and haPWV in our
findings. The relationship between CAVI and body com-
position defined as true lean body or fat mass have been
reported in a population-based study. Nagayama et al.
[28] reported that CAVI was associated with baseline an-
thropometric indices and decreased after reduction in
body weight by caloric restriction. The association be-
tween obesity and arterial stiffening might be attrib-
uted to insulin resistance, reduction in nitric oxide
synthesis and pro-inflammatory state associated with
obesity [33, 34].
Blood vessel damage in T2D is also characterised by
resistance vessel hypertrophy and endothelial leakage (as
in ‘micro’-albuminuria) [35]. Hypertension without
diabetes is characterised by ‘eutrophic’ remodelling of
resistance vessels without hypertrophy, at least, until de-
compensation occurs, leading to increased endothelial
dysfunction and peripheral vascular resistance [36].
These pathophysiological trajectories are interlinked in
several ways; T2D and hypertension induce changes in
arterial structure through similar yet independent path-
ways [37]. The mechanism by which T2D per se contrib-
utes to increased arterial stiffness and hypertension is
not yet certain [36]. However, decreased nitric oxide
activity, activation of the renin-angiotensin system, mito-
gen activated kinase pathways, advanced glycated end-
product generation and increased oxidative stress all
seem to contribute in T2D [17, 38]. CAVI has recently
been shown to correlate with oxidized lipoprotein(a) in
older [30], but not younger [24], patients, and is associ-
ated with changes in oxidative stress status in T2D pa-
tients with abnormal levels of LDL [39]. However, the
physiological mechanisms underlying elevated arterial
stiffness in T2D and hypertensive patients in these
Ghanaian patients will need biopsy and post-mortem
studies to clarify tissue pathology.
The limitations of this study were its cross-sectional
nature, hospital-based cases under treatment and the
relatively small number of community-based healthy
controls (n = 28), might give enough power for analysis.
Future studies with prospective designs should provide
valuable information about the utility of various indices
of arterial stiffness in African populations.
Conclusion
This study has shown indices of arterial stiffness,
particularly, CAVI and haPWV, are useful tools for
screening and discrimination of cardiovascular risk sta-
tus in Ghanaian patients with T2D and hypertension.
These indices may offer more precise targets for treat-
ment than (higher) BP alone, particularly in low resource
sub-Saharan African setting.
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